Beskrivning
| Land | Norge |
|---|---|
| Lista | OAX Equities |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
Oslo, 12 December 2025 - Observe Medical ASA (the "Company" or "Observe Medical") announces expansion of portfolio, progress on commercial journey and in the development of UnoMeter™ Safeti™ Max.
The Company is launching an extension of its portfolio of products within the category of Urological Drainage. The launch includes 3 new products: a front mounted UnoMeter which is a preference in some markets and 2 Closed System products which are sterile solutions used widely within hospitals globally. In combination it is estimated the global market value of these products are at a level of 1,6-1,8 bill. NOK.
Jørgen Mann, CEO of Observe Medical, commented: "We have a strong distribution platform with a wide geographical reach and it is a logical step to introduce an extended range which will give us access to a global market which has a market value of more than 1,5 bill. NOK. The new products, which are part of the same category as the UnoMeter's, will give us additional growth potential and we can now offer a more complete range in the category of Urological Drainage which will offer extended value to both our distributors and the hospitals."
The Company sees continued positive development as the market penetration continues and we are continuously seeing additional hospital and contract wins in many markets including the Spanish, German, Swiss and Portuguese markets.
The development of UnoMeter™ Safeti™ Max continues to be on track with manufacturing capabilities being established, certification preparation progressing and we have seen the first positive results on the clinical performance of the product.
For further information, please contact:
Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com
Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in urine measurement and ultrasound, in combination with targeted M&A and distribution. Observe Medical is working with a network of leading distributors to provide outstanding solutions for healthcare professionals globally.
The Company is headquartered in Oslo, Norway.
Further information is available at www.observemedical.com.